A detailed history of Nichols & Pratt Advisers LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 5,050 shares of EW stock, worth $473,589. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,050
Previous 5,050 -0.0%
Holding current value
$473,589
Previous $385,000 25.19%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$72.54 - $95.56 $366,327 - $482,578
5,050 New
5,050 $482,000
Q4 2023

Feb 07, 2024

BUY
$61.71 - $77.76 $311,635 - $392,688
5,050 New
5,050 $385,000
Q4 2021

Feb 08, 2022

SELL
$106.37 - $130.68 $85,096 - $104,544
-800 Reduced 13.68%
5,050 $654,000
Q2 2020

Aug 10, 2020

BUY
$57.54 - $76.95 $210,021 - $280,867
3,650 Added 165.91%
5,850 $404,000
Q2 2017

Aug 08, 2017

BUY
N/A
2,200
2,200 $260,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $58B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nichols & Pratt Advisers LLP Portfolio

Follow Nichols & Pratt Advisers LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.